Immunotherapy and targeted therapy of advanced non-small cell lung carcinoma: Treatment benefits and cost in an unselected real-life population

About the project

• Project period: 01.07.2021 - 31.12.2024 (Concluded)
• Coordinating Institution: Norwegian Institute of Public Health
• Project Manager:
  • Bettina Kulle Andreassen, The Cancer Registry of Norway, Norwegian Institute of Public Health
• Project Participants:
  • Helga Helseth Hektoen, The Cancer Registry of Norway, Norwegian Institute of Public Health
  • Giske Ursin, The Cancer Registry of Norway, Norwegian Institute of Public Health
• • See more information and results in the Norwegian Research Information Repository (NVA)